Financhill
Back

Can Fite Biofarma Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
42

CANF
Can Fite Biofarma

Last Price:
2.19
Seasonality Move:
-3.85%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Can Fite Biofarma Price Quote

$2.19
+0.03 (+1.39%)
(Updated: November 4, 2024 at 5:55 PM ET)

Can Fite Biofarma Key Stats

Sell
42
Can Fite Biofarma (CANF) is a Sell

Day range:
$2.04 - $2.25
52-week range:
$1.83 - $4.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.31%

Volume:
31.6K
Avg. volume:
119K
1-year change:
1.41%
Market cap:
$13.2M
Revenue:
$743K
EPS:
$-3

How Much Does Can Fite Biofarma Make?

Is Can Fite Biofarma Growing As A Company?

  • What Is Can Fite Biofarma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.21%
  • What Is Can Fite Biofarma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Can Fite Biofarma Stock Price Performance

What Is Can Fite Biofarma 52-Week High & Low?

Can Fite Biofarma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Can Fite Biofarma?

  • How Much Debt Does Can Fite Biofarma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Can Fite Biofarma Have?
    Cash and short term investments quarterly total is $8.9M
  • What Is Can Fite Biofarma’s Book Value Per Share?
    Book value per share is 1.38

Is Can Fite Biofarma Cash Flow Positive?

Data Unavailable

Can Fite Biofarma Return On Invested Capital

  • Is Management Doing A Good Job?
    CANF return on invested capital is -121.88%
  • What Is Can Fite Biofarma Return On Assets?
    ROA measures how assets are converting to revenues and is -72.07%
  • What Is CANF Return On Equity?
    ROE is a measure of profitability and is -121.88%

Can Fite Biofarma Earnings Date & Stock Price

Can Fite Biofarma Competitors

Can Fite Biofarma Dividend Yield

Can Fite Biofarma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -710.81%
Revenue: -21.32% -22.5%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.33
Upside from Last Price: 517.28%

Major Shareholders

  • How many CANF shares are owned by institutional investors?
    695.1K CANF shares are owned by institutional investors
  • How many CANF shares are owned by insiders?
    0 CANF shares are owned by insiders